Danicopan, which is already approved in Japan as Voydeya and under regulatory review in the US, is intended as an add-on therapy to complement C5 inhibitors like AZ’s own Soliris (eculizumab ...

Investors will be keen to know the sales number of AstraZeneca’s new products Airsupra (asthma), Voydeya (paroxysmal nocturnal hemoglobinuria) and Wainua (ATTRv-PN) as well as AstraZeneca and ...

Investors will be keen to know the sales number of AstraZeneca’s new products Airsupra (asthma), Voydeya (paroxysmal nocturnal hemoglobinuria) and Wainua (ATTRv-PN) as well as AstraZeneca and partner ...

Shares of the British-Swedish pharmaceutical titan AstraZeneca are trading 7% lower in London today as investors price in the acquisition of Alexion Pharmaceuticals for $39 billion. A deal, which is ...

Credit: Getty Images The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products. Below is a review of novel drug and biological products ...

Want to brand your business without breaking the bank? The best free logo maker will be an essential tool in your marketing kit - and after testing these completely free logo designers ...

We've been getting creative with the best logo makers for branding your business online. It's difficult to understate the importance of good logo design - it's the quickest way for customers and ...

The company’s medicinal brands comprise Kanuma, Koselug, Soliris, StrensIQ, Ultomiris and Voydeya. Alexion collaborates with various research organizations and pharmaceutical companies. The company ...

The list includes several groundbreaking therapies that are expected to change the treatment landscape for several diseases and conditions. Below is a review of novel drug and biological products ...